Min-Hyo Ki

Title: **Innovator Spotlight: Min-Hyo Ki and His Contribution to Ophthalmic Solutions**

Introduction

Min-Hyo Ki, an esteemed inventor based in Chungcheong-nam-do, South Korea, has made significant strides in the field of ophthalmology. His innovative work has led to the development of a pioneering ophthalmic composition that addresses the challenges faced by patients suffering from dry eye.

Latest Patents

Min-Hyo Ki holds a patent for an ophthalmic composition comprising rebamipide, as well as a method for preparing the same. This composition is designed to maintain its transparency over prolonged periods, even within a physiologically neutral to weakly basic pH range. Notably, the formulation does not cause harm to the cornea and conjunctiva, offering an effective solution for individuals experiencing dry eye symptoms. Furthermore, the composition boasts improved stability, ensuring that it does not re-disperse, thereby enhancing its usability and efficacy.

Career Highlights

Min-Hyo Ki works at Samjin Pharmaceutical Co., Ltd., a company dedicated to advancing healthcare through innovative pharmaceutical solutions. His contributions to the field of ophthalmology, particularly in creating this ophthalmic composition, underscore his commitment to improving patient care.

Collaborations

Throughout his career, Min-Hyo Ki has collaborated with notable colleagues, including Eui-Hwan Cho and Sung-Ju Choi. Together, they have combined their expertise and innovative ideas to develop groundbreaking solutions in the pharmaceutical field, further solidifying their impact on healthcare.

Conclusion

Min-Hyo Ki's work serves as an inspiration within the pharmaceutical community, exemplifying how innovation and collaboration can lead to significant advancements in patient care. With his patent for the ophthalmic composition, he continues to pave the way for new treatments and solutions for those affected by dry eye, making a lasting difference in the field of ophthalmology.